- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0056076

About Erythro Pharma Private Limited
Data last updated:
Erythro Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 February 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1991PTC012286. Its GSTIN is 36AAACE4548C1ZY (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.8 Cr. It was formerly known as Lake View Labs Private Limited. It is led by directors including Rajagopala Reddy Duvvuru (Managing Director) and Balachandra Reddy Duvuru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No.212 Bhanu Enclave Near E.S.I. Hospital Erragadda, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.06 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹2.92 Cr (net margin 7.3%) and EBITDA of ₹5.81 Cr (EBITDA margin 14.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 14% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Erythro Pharma. As per MCA filings, the company has open charges of ₹16.48 Cr and satisfied charges of ₹1.8 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Erythro Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0056076). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website erythropharma.com.
Company details
CIN history
Erythro Pharma has one previous CIN (Corporate Identification Number): U24239AP1991PTC012286. The current CIN is U24239TG1991PTC012286, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1991PTC012286 | Current |
| U24239AP1991PTC012286 | Previous |
Recognitions & Rankings of Erythro Pharma
Contact details
Erythro Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is erythropharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressFlat No.212 Bhanu Enclave Near E.S.I. Hospital Erragadda, Hyderabad, Telangana, India – 500038
- IndustryPharma, API Manufacturers
To see the full contact details of Erythro Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Erythro Pharma operates one associated brand: Erythro Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract manufacturing, R&D, and supply of pharmaceutical intermediates worldwide. | erythropharma.com |
Business activity
The main business activity of Erythro Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Erythro Pharma Private Limited, buy the company report.
Financials of Erythro Pharma Private Limited
FY 2025 filings availableErythro Pharma Private Limited reported revenue of ₹40.06 Cr (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 48% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.81 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.5% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Erythro Pharma Private Limited, buy the company report.
Board of directors of Erythro Pharma Private Limited
Erythro Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balachandra Reddy Duvuru Also directs: Threo Laboratories Private Limited | Director | 19 Jan 1998 | 28 Years 9 Months | Current |
| Rajagopala Reddy Duvvuru Also directs: Threo Laboratories Private Limited | Managing Director | 01 Jul 2003 | 23 Years 4 Months | Current |
| Duvvuru Abhiram Also directs: Greenlit CV Energy LLP, Activin Biosciences Private Limited, Enpiar Pharma Private Limited and 4 more | Director | 05 Feb 2018 | 8 Years 9 Months | Current |
Peer comparison
Erythro Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Qualikems Lifesciences Private Limited | ₹41.7 Cr (FY 2025) | 13.0% | Vadodara, Gujarat, India | |||
| Assurgen Pharma Private Limited | ₹41.36 Cr (FY 2025) | -3.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Elixir Pharma Chem Private Limited | ₹41.04 Cr (FY 2025) | 86.0% | Ahmedabad, Gujarat, India | |||
| Stermone Chemicals Private Limited | ₹40.62 Cr (FY 2024) | 1.0% | Khambhat, Gujarat, India | |||
| Erythro Pharma Private Limitedthis company | ₹40.06 Cr (FY 2025) | ₹2.92 Cr | 7.3% | 48.0% | 33 | Hyderabad, Telangana, India |
| Cureworth Drugs & Intermediates Private Limited | ₹40.05 Cr (FY 2025) | 79.0% | Panvel, Maharashtra, India | |||
| Viswa Laboratories Private Limited | ₹39.96 Cr (FY 2025) | 1.0% | Pune, Maharashtra, India | |||
| SLR Pharma Private Limited | ₹39.77 Cr (FY 2024) | -25.0% | Hyderabad, Telangana, India | |||
| Chaitanya Biologicals Private Limited | ₹39.58 Cr (FY 2025) | -7.0% | Malkapur, Maharashtra, India | |||
| Shruti Drugs Private Limited | ₹39.47 Cr (FY 2025) | 35.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Erythro Pharma Private Limited, buy the company report.
Auditor
Erythro Pharma Private Limited is audited by SURYACHANDRA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURYACHANDRA & ASSOCIATES | FY 2023 | 004297S |
Shareholding
The shareholding of Erythro Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Erythro Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jul 2007 | 10065933 | Others | ₹13.53 Cr | Open | |
| 08 Sep 2001 | 90138310 | Union Bank of India | ₹1.25 Cr | Open | |
| 09 Feb 2000 | 90138184 | Union Bank of India | ₹95 Lakh | Open | |
| 02 Jun 1999 | 90138127 | Union Bank of India | ₹50 Lakh | Open | |
| 27 Sep 1996 | 90137907 | Union Bank of India | ₹25 Lakh | Open |
To see the full charge records of Erythro Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Erythro Pharma Private Limited has 2 court cases on record: 2 filed by Erythro Pharma. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Threo Laboratories Private Limited, and 2 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The Government of Andhra Pradesh, and 4 others | Disposed |
To see the full case history of Erythro Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erythro Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Erythro Pharma Private Limited has a workforce of 33 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
GST
Erythro Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACE4548C1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Erythro Pharma Private Limited, buy the company report.
Recent activity
Erythro Pharma Private Limited has 3 board changes on record since 1998: 3 appointments. The latest: Duvvuru Abhiram was appointed as Director on 05 Feb 2018.
5 earlier events are in the company report.
Frequently asked questions
Erythro Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 February 1991 (35+ years old) and is registered under CIN U24239TG1991PTC012286.
Erythro Pharma has 3 current directors:
- Rajagopala Reddy Duvvuru - Managing Director
- Balachandra Reddy Duvuru - Director
- Duvvuru Abhiram - Director
The latest financial statements of Erythro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Erythro Pharma is 36AAACE4548C1ZY, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Erythro Pharma is U24239TG1991PTC012286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erythro Pharma has 2 court cases on record: 2 filed by the company. 1 is pending.
Erythro Pharma was incorporated on 05 February 1991, making it 35+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Erythro Pharma by revenue are Qualikems Lifesciences Private Limited, Assurgen Pharma Private Limited, Elixir Pharma Chem Private Limited, Stermone Chemicals Private Limited, Cureworth Drugs & Intermediates Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Duvvuru Abhiram was appointed as Director on 05 Feb 2018. Rajagopala Reddy Duvvuru was appointed as Managing Director on 01 Jul 2003. Balachandra Reddy Duvuru was appointed as Director on 19 Jan 1998.
Yes, Erythro Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0056076).
Erythro Pharma can be reached through the website erythropharma.com. Its registered office is in Hyderabad, Telangana, India.

